Amrize initiated with an Outperform at Oppenheimer

Oppenheimer analyst Bryan F. Blair initiated coverage of Amrize (AMRZ) with an Outperform rating and $62 price target implying 13% upside potential vs. the current trade. The firm appreciates Amrize’s advantaged footprint and resource base, structural pricing power, and robust/sustainable margin generation – together positioning the franchise to leverage stronger North American construction demand in 2026 and beyond. Adding solid free cash flow generation and capital deployment optionality, Oppenheimer likes Amrize’s prospects for double-digit earnings growth through the cycle. Given that setup and supportive trading multiples, the firm believes its initial modeling and valuation rationale lean conservative.